Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ＮＫＧ２Ｄ、ＣＤ１６及び腫瘍関連抗原に結合するタンパク質
Document Type and Number:
Japanese Patent JP2021533159
Kind Code:
A
Abstract:
ＮＫＧ２Ｄ受容体、ＣＤ１６並びにｃ−ＭＥＴ、ＫＩＴ、Ｆ３、ＩＧＦ１Ｒ、Ｌｅｗｉｓ Ｙ、ＭＵＣ１３、ＭＵＣ４、ＭＣＡＭ、ＬＲＲＣ３２、シアリルＴｎ、ｇｐＡ３３、ＧＤ３、ＧＭ２、ＥＰＨＡ３、ＴＮＦＲＳＦ１０Ａ、ＴＮＦＳＦ１１、ＣＤ７４及びＰＭＥＬから選択される腫瘍関連抗原に結合する多特異性結合性タンパク質のほか、がんの処置に有用な、医薬組成物及び治療法について記載される。

More Like This:
WO/2018/137609ANTIBODY CONJUGATE, AND RELATED PHARMACEUTICAL COMPOSITION AND APPLICATION
WO/2017/143838BIVALENT BISPECIFIC ANTIBODY HYBRID PROTEIN EXPRESSION AND PREPARATION METHODS
JP5391073Ovr110 antibody composition and usage
Inventors:
Chan, Gregory Pee
Chan, Ann F
Do, Jin Yang
Grimberg, Asya
Haney, William
Runde, Bradley M
Prinz, Bianca
Application Number:
JP2021506442A
Publication Date:
December 02, 2021
Filing Date:
August 08, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Dragonfly Therapeutics, Incorporated
International Classes:
C07K16/46; A61K38/02; A61K39/395; A61P35/00; A61P35/02; C07K16/28; C07K16/32; C12N1/15; C12N1/19; C12N1/21; C12N5/09; C12N5/10
Domestic Patent References:
JP2013500721A2013-01-10
JP2012510280A2012-05-10
JP2017514491A2017-06-08
JP2018502572A2018-02-01
Foreign References:
US20170368169A12017-12-28
WO2016207273A22016-12-29
Other References:
HUMAN VACCINES & IMMUNOTHERAPEUTICS, vol. 12, no. 11, JPN6021051696, 2016, pages 2790 - 2796, ISSN: 0005119326
EXPERT OPINION ON BIOLOGICAL THERAPY, vol. Vol. 16, Issue 9, JPN6023030915, 9 June 2016 (2016-06-09), pages 1105 - 1112, ISSN: 0005119327
Attorney, Agent or Firm:
Kawaguchi International Patent Office



 
Previous Patent: How to carry out treatment

Next Patent: How to make carbonic acid ester